SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q1 EPS of ($0.26), $0.04 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $17.8 million versus the consensus estimate of $16.75 million.

GUIDANCE:

SOPHiA GENETICS SA sees FY2025 revenue of $72-76 million, versus the consensus of $73.48 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.